Products

Introducing Cinnovir Logo

Following the discovery that cinnamon polyphenol fraction (PPF) can assist in neutralizing viruses (see ), Novid-20 has made significant technological innovations:Antiviral Platform

  • Development of an all-natural full-scale process to extract PPF from raw cinnamon without involving any chemicals.
  • Development of an industrial process for production of PPF-enriched, tasty, sugar-free lozenges for consumption as a food supplement.

PPF Features

  • Isolated by a physical industrial separation technology (no chemicals)
  • A specific, reproducible, unique process
  • The specific cinnamon fraction responsible for its antiviral effect was unknown until PPF was characterized and defined by us
  • Both the compound and the technological process are patent pending. Patent rights will be pursued globally.
  • Stable product – insensitive to elevated temperatures and storage conditions
  • PPF is branded Cinnovir

IP

(the active compound), as well as the technology of its production, are proprietary and patent pending (IL277753 & IL283292, PCT/IL2021/051186). Additional patents related to the anti-Herpes and animal applications are under way.Cinnovir

Novid Products

  • Product 1(ready)Cinnovir water extract with 10% active content (polyphenol anti-viral compound produced from cinnamon)
  • Product 2 (ready)CinnovirLozenges (Sugar-free, appealing lozenges. Sucking a lozenge causes the slow release of the active compound, coating the buccal cavity with this compound)
  • Product 3(ready)Cinnovircosmetic therapeutic gel (an experimental anti-Herpes gel based onCinnovir has been formulated)
  • Product 4 (R&D)Cinnovir for animal health(Projected to be applicable against:
      • Avian flu
      • Porcineviruses

Wrapped Lozenges Cinnovir

Unwrapped LozengesCinnovir

Industrial production of has already started.Cinnovir

What We Know

  • is an inexpensive, safe, and naturally derived compound, representing only 2.5% of the volume of the cinnamon bark. Its polyphenol content is as much as 90%.Cinnovir
  • has a pronounced broad-spectrum antiviral capability.Cinnovir
  • do not require refrigeration and can therefore be easily stored, handled and transported to distant locations, including developing countries.Cinnovir & Cinnovir Lozenges
  • According to lab studies: and related products are effective against Herpes 1, Covid-19, Influenza and several animal viruses. Cinnovir

What We Hope to Demonstrate

In human studies:

  • , and significantly shorten and alleviate the outbreak of Herpes 1CinnovirCinnovir lozengesCinnovir Gel
  • , significantly reduce the viral load and hence can provide an additional protective layer against Covid-19CinnovirCinnovir lozenges

In animal studies:

  • Efficacy of Cinnovir in prevention of Avian Flu, bovine and porcine viral diseases.

Pricing

Anti-Herpes-1 applications

Wholesale price of one 20-lozenge pack (amount needed for one outbreak) is $4.50.

Anti Covid

The projected wholesale price of the recommended daily dose for the individual exposed to Covid-19 (five lozenges) is $0.8. This is a very low-cost solution, affordable to a wide spectrum of households. For prophylactic purposes, consumption, and hence price, can be a fraction of this sum.

Animal applications

  • If added to drinking water: $0.001 per day per chicken
  • If added to drinking water: $0.01 per day per pig

Regulatory

At present, Cinnovir and Cinnovir lozenges can only be marketed as food supplements. Investigation is currently under way to determine whether, according to European regulations, Cinnovir can be classified as a “device,” given that the product operates as a barrier and is not involved in biochemical interactions; this would correspond to Class II Approval. Clinical studies related to Herpes 1 are envisaged shortly.

Disclaimer

At present, Cinnovir and Cinnovir lozenges are marketed strictly as nutritional supplements. No explicit or implied medical claims with respect to their potential antiviral activity are made. All content on this website is provided for informational purposes only. The reader is called upon to exercise caution, consult with doctors and other professionals, and make independent educated decisions regarding consumption of Cinnovir and Cinnovir lozenges.

Novid-20 thereby disclaims all responsibility for the efficacy or undesirable side effects of these products. We accept no liability whatsoever for any decision made or action taken or not taken.